» Articles » PMID: 20154680

TGF-beta-mediated Phosphorylation of HnRNP E1 Induces EMT Via Transcript-selective Translational Induction of Dab2 and ILEI

Overview
Journal Nat Cell Biol
Specialty Cell Biology
Date 2010 Feb 16
PMID 20154680
Citations 180
Authors
Affiliations
Soon will be listed here.
Abstract

Transforming growth factor-beta (TGF-beta) induces epithelial-mesenchymal transdifferentiation (EMT) accompanied by cellular differentiation and migration. Despite extensive transcriptomic profiling, the identification of TGF-beta-inducible, EMT-specific genes has met with limited success. Here we identify a post-transcriptional pathway by which TGF-beta modulates the expression of EMT-specific proteins and of EMT itself. We show that heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1) binds a structural, 33-nucleotide TGF-beta-activated translation (BAT) element in the 3' untranslated region of disabled-2 (Dab2) and interleukin-like EMT inducer (ILEI) transcripts, and represses their translation. TGF-beta activation leads to phosphorylation at Ser 43 of hnRNP E1 by protein kinase Bbeta/Akt2, inducing its release from the BAT element and translational activation of Dab2 and ILEI messenger RNAs. Modulation of hnRNP E1 expression or its post-translational modification alters the TGF-beta-mediated reversal of translational silencing of the target transcripts and EMT. These results suggest the existence of a TGF-beta-inducible post-transcriptional regulon that controls EMT during the development and metastatic progression of tumours.

Citing Articles

Regulatory roles of RNA binding proteins in the Hippo pathway.

Peng S, Li C, He Y, Xue L, Guo X Cell Death Discov. 2025; 11(1):36.

PMID: 39890775 PMC: 11785755. DOI: 10.1038/s41420-025-02316-z.


Identification of RNA structures and their roles in RNA functions.

Cao X, Zhang Y, Ding Y, Wan Y Nat Rev Mol Cell Biol. 2024; 25(10):784-801.

PMID: 38926530 DOI: 10.1038/s41580-024-00748-6.


Alternative splicing in EMT and TGF-β signaling during cancer progression.

Zhang Y, Stuelten C Semin Cancer Biol. 2024; 101:1-11.

PMID: 38614376 PMC: 11180579. DOI: 10.1016/j.semcancer.2024.04.001.


Disable 2, A Versatile Tissue Matrix Multifunctional Scaffold Protein with Multifaceted Signaling: Unveiling Role in Breast Cancer for Therapeutic Revolution.

Shah N, Dave B, Shah K, Shah D, Maheshwari K, Chorawala M Cell Biochem Biophys. 2024; 82(2):501-520.

PMID: 38594547 DOI: 10.1007/s12013-024-01261-5.


Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle.

Shah N, Dave B, Shah K, Shah D, Maheshwari K, Chorawala M Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(8):5533-5557.

PMID: 38502243 DOI: 10.1007/s00210-024-03037-3.


References
1.
Greinwald Jr J, Wayne S, Chen A, Scott D, Zbar R, Kraft M . Localization of a novel gene for nonsyndromic hearing loss (DFNB17) to chromosome region 7q31. Am J Med Genet. 1998; 78(2):107-13. View

2.
Brazil D, Hemmings B . Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci. 2001; 26(11):657-64. DOI: 10.1016/s0968-0004(01)01958-2. View

3.
Bierie B, Moses H . TGF-beta and cancer. Cytokine Growth Factor Rev. 2005; 17(1-2):29-40. DOI: 10.1016/j.cytogfr.2005.09.006. View

4.
Thiery J, Sleeman J . Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006; 7(2):131-42. DOI: 10.1038/nrm1835. View

5.
Miettinen P, Ebner R, Lopez A, Derynck R . TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol. 1994; 127(6 Pt 2):2021-36. PMC: 2120317. DOI: 10.1083/jcb.127.6.2021. View